FREUND CORPORATION – Trademark Portfolio
Entity Type: 03
FREUND CORPORATION holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 7 (Machinery) — 15 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 12 trademarks are registered. Notable registered marks include FREUND, COATREX, SPHEREX, GRANUREX, and DILACTOSE. The owner is based in Tokyo 169-0072.
1-3-21, Okubo, Shinjuku-ku
Tokyo 169-0072 , JP
Showing of trademarks Trademarks
Trademark Classifications
FREUND CORPORATION's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Machines and machine tools; motors and engines; machine coupling and transmission components
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does FREUND CORPORATION have?
FREUND CORPORATION has 19 U.S. trademarks filed with the USPTO. Of these, 12 registered, 3 abandoned, 4 cancelled.
What trademark classes does FREUND CORPORATION file in?
FREUND CORPORATION files trademarks across 3 Nice Classification classes. The most active classes are Class 7 (Machinery), Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 7 covers machines and machine tools; motors and engines; machine coupling and transmission components.
What are FREUND CORPORATION's most well-known trademarks?
FREUND CORPORATION's registered trademark portfolio includes well-known marks such as FREUND, COATREX, SPHEREX, GRANUREX, and DILACTOSE. These are among 12 currently registered trademarks in the portfolio.
What is FREUND CORPORATION's trademark registration success rate?
FREUND CORPORATION has a 63% trademark registration rate, with 12 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.